Researchers sought to better understand the connection between REM sleep patterns in patients with either insomnia or MDD.

The FDA has removed the risk evaluation and mitigation strategies (REMS) program requirement for Tryvio (aprocitentan).

The FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy ...

MMS, an award-winning, data-focused clinical research organization (CRO), is showcasing its expansion as a tech-enabled, full-service Risk Evaluation and Mitigation Strategies (REMS) solutions ...

Cytokinetics has a strong cash runway but faces risks from its Royalty Pharma deal. Read more on what's ahead for this ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...

Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...

As health officials continue to issue warnings about the dangers of alcohol, it might be time to ditch the nightly habit.

However, some research shows that major stressors may increase REM sleep but reduce deep sleep. REM rebound, which is when we ...

Justice minister says drug consumption rooms, where users can safely inject, would be a step forward. As the president tries to force Mexico to stop the flow of drugs, cartel members tell Quentin ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...